` Comparison: CBDN vs 002001 - Alpha Spread

C
CBDN
vs
002001

Over the past 12 months, CBDN has underperformed Zhejiang Nhu Co Ltd, delivering a return of 0% compared to the Zhejiang Nhu Co Ltd's +50% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
CBDN
002001
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

C
CBDN Intrinsic Value
Not Available
Intrinsic Value
33.72 CNY
Overvaluation 1%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Multiples-Based Value Wall St Target
C
Cbd Global Sciences Inc
CNSX:CBDN
0.045 CAD
Zhejiang Nhu Co Ltd
SZSE:002001
33.97 CNY
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
CBDN, 002001

CBDN
002001
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
C
Cbd Global Sciences Inc
Revenue
Zhejiang Nhu Co Ltd
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
CBDN, 002001

CBDN
002001
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
C
Cbd Global Sciences Inc
CNSX:CBDN
Zhejiang Nhu Co Ltd
SZSE:002001
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

CBDN
72.2%
Zhejiang Nhu Co Ltd
44.9%

Operating Margin

CBDN
-844.9%
Zhejiang Nhu Co Ltd
37.2%

Net Margin

CBDN
-941%
Zhejiang Nhu Co Ltd
32%

FCF Margin

CBDN
-61.4%
Zhejiang Nhu Co Ltd
27.5%

ROE

CBDN
188.9%
Zhejiang Nhu Co Ltd
24.1%

ROA

CBDN
-994.3%
Zhejiang Nhu Co Ltd
16.6%

ROIC

CBDN
1 912.3%
Zhejiang Nhu Co Ltd
21.7%

ROCE

CBDN
509.8%
Zhejiang Nhu Co Ltd
23%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
CBDN, 002001

Loading
CBDN
002001
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
CBDN, 002001

Loading
CBDN
002001
Difference
www.alphaspread.com

Performance By Year
CBDN, 002001

Loading
CBDN
002001
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare CBDN to other stocks
SUNPHARMA
Sun Pharmaceutical Industries...
Cheaper
vs CBDN
SDZ
Sandoz Group AG
S
Cheaper
vs CBDN
DD
Dupont De Nemours Inc
Cheaper
vs CBDN
300765
CSPC Innovation Pharmaceutical...
C
Cheaper
vs CBDN
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett